Allumia Ventures
Venture capitalBellevue · Series A–Late Stage · 5 people tracked
Investment thesis
Allumia Ventures is a venture capital firm established in 2015 that invests in digital health, technology-enabled healthcare services, and medical device companies. The firm was previously named Providence Ventures.
Team · 5 people
from the firm's websiteFrequently asked questions
- What stage does Allumia Ventures invest at?
- Allumia Ventures invests at the Series A, Series B, Series C, Late Stage stages.
- What is Allumia Ventures's typical check size?
- Allumia Ventures typically writes checks of $5M – $15M.
- What sectors does Allumia Ventures focus on?
- Allumia Ventures focuses on Enterprise Software, Healthtech, Medical Devices.
- Where is Allumia Ventures located?
- Allumia Ventures is headquartered in Bellevue, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.